Cooley

Sharon Connaughton

Deals
6
Latest
Jun 2026
Most deals in
Biotech

Firm

  • Cooley Law firm · 2026 · 6 deals
Deals by year
Sharon Connaughton: deals by year03620252026 YTD: 5 M&A2026 YTD: 1 Equity raisings62026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Sharon Connaughton was named on, most recent first
Jun 2026 First Street –MSCIAcquisitionLegal adviser to First Street (target)Announced120.0Data & Analytics+1MSCI acquisition of First Street
May 2026 Peloton Consulting Group –Sunstone PartnersStakeLegal adviser to Peloton Consulting Group (target)Announced–IT Services+1Sunstone Partners stake in Peloton Consulting Group
May 2026 RockCreek –Brown AdvisoryStakeLegal adviser to Brown Advisory (acquirer)Announced–Asset & Wealth ManagementBrown Advisory stake in RockCreek
May 2026 Polaris DS –Core ScientificAcquisitionLegal adviser to Core Scientific (acquirer)Announced461.0Data Centers+1Core Scientific acquisition of Polaris DS
May 2026 Candid Therapeutics –UCBAcquisitionLegal adviser to Candid Therapeutics (target)Announced2,200.0Biotech+1UCB acquisition of Candid Therapeutics
Mar 2026 Candid Therapeutics ––PlacementLegal adviser to the issuerPending505.0Biotech+1Candid Therapeutics placement

Deals where Sharon Connaughton is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.